Maternal and neonatal outcomes in placenta accreta spectrum: Influence of antenatal diagnosis and surgical strategy
PDF
Cite
Share
Request
Clinical Investigation
E-PUB
22 January 2026

Maternal and neonatal outcomes in placenta accreta spectrum: Influence of antenatal diagnosis and surgical strategy

Turk J Obstet Gynecol. Published online 22 January 2026.
1. İnönü University Faculty of Medicine, Department of Obstetrics and Gynecology, Malatya, Türkiye
2. KTO Karatay University Faculty of Medicine, Department of Obstetrics and Gynecology, Konya, Türkiye
3. İnönü University Faculty of Medicine, Department of Biostatistics and Medical Informatics, Malatya, Türkiye
No information available.
No information available
Received Date: 24.08.2025
Accepted Date: 01.11.2025
E-Pub Date: 22.01.2026
PDF
Cite
Share
Request

Abstract

Objective

This study aimed to evaluate the influence of antenatal diagnosis and surgical management strategies on maternal and neonatal outcomes in placenta accreta spectrum (PAS) disorders, emphasizing risk factors, timing of delivery, and operative approaches.

Materials and Methods

A retrospective cohort analysis was conducted on 210 women with histopathologically confirmed PAS managed at İnönü University Faculty of Medicine between January 2014 and March 2024. Demographic data, antenatal findings, delivery type, and surgical details were compared between elective and emergency procedures, as well as between uterus-preserving surgery and peripartum hysterectomy. Uterus-preserving surgery refers to conservative techniques that aim to avoid peripartum hysterectomy while controlling hemorrhage.

Results

Of the total cohort, 66.7% underwent elective surgery, whereas 33.3% required emergency intervention. Emergency deliveries occurred earlier (mean 32.1 vs. 36.0 weeks, p<0.001) and were associated with higher blood loss (799 vs. 511 mL, p<0.001), increased perinatal mortality (20% vs. 1.4%, p<0.001), and greater neonatal morbidity, mainly respiratory distress syndrome (47% vs. 14%, p<0.001). Hysterectomy was required in 45.2% of patients, primarily with placenta percreta (60% vs. 23.5%, p<0.001). Anterior placental location (89.5%) strongly correlated with complete invasion (77.7%) and bladder involvement (27.7%, p=0.038). Bladder injuries were more common in elective cases, while ureteral injuries occurred more often in emergencies (p=0.024). Preoperative hematocrit independently predicted hysterectomy risk (odds ratio: 1.092, p=0.034).

Conclusion

Antenatal diagnosis and well-planned elective management significantly improve maternal and neonatal outcomes in PAS. Individualized surgical planning based on invasion depth and maternal condition remains essential to reduce morbidity and mortality.

Keywords:
Intraoperative complications, placenta accreta, pregnancy outcome, prenatal diagnosis

PRECIS: Timely antenatal diagnosis and elective management markedly reduce maternal morbidity and perinatal mortality in placenta accreta spectrum, underscoring the importance of planned multidisciplinary prenatal care.

Introduction

Placenta accreta spectrum (PAS) disorders were historically attributed to abnormal trophoblastic invasion. However, current understanding indicates that they arise primarily from uterine scarring and defective decidualization, which lead to a distorted uteroplacental interface and aberrant fibrinoid deposition rather than true villous invasiveness(1). It is associated with substantial maternal morbidity and mortality, primarily due to massive hemorrhage, increased transfusion requirements, multi-organ injury and, in severe cases, maternal death. The global incidence of PAS has risen markedly over recent decades, a trend largely attributed to the parallel increase in cesarean delivery rates(2). While planned preterm cesarean hysterectomy without attempts at placental removal remains the most widely accepted standard management, this approach entails irreversible loss of fertility and significant psychological impact for many women. Consequently, alternative uterus-preserving surgical techniques have been explored in selected cases(3).

The pathogenesis of PAS is intrinsically linked to defective decidualization of the endometrium, most commonly occurring at sites of previous uterine scarring from cesarean sections, myomectomies, or other surgical interventions. This defective decidualization results in failure of normal placental separation after delivery, leading to massive hemorrhage that often necessitates emergency hysterectomy(4). Therefore, accurate antenatal diagnosis is critical for optimizing outcomes. Ultrasound, particularly with the adjunct of color Doppler imaging, remains the primary diagnostic modality, offering high sensitivity and specificity when performed by experienced operators(5). Magnetic resonance imaging (MRI) is valuable in cases with posterior placental implantation or suspected lateral extension(6). Key sonographic signs—such as placental lacunae, myometrial thinning, and loss of the hypoechoic retroplacental zone—alongside subplacental hypervascularity on Doppler imaging, provide essential diagnostic clues. The identification of risk factors, including a history of cesarean section, placenta previa, prior uterine surgery, advanced maternal age, and multiparity, further refines clinical suspicion(7).

The clinical implications of PAS extend beyond immediate maternal risks to encompass significant neonatal morbidity. Preterm delivery, whether iatrogenic or spontaneous, is a near-universal consequence, with studies demonstrating that elective delivery at 34-36 weeks in specialized centers optimizes outcomes by balancing fetal maturity against the risk of emergent hemorrhage(8). However, the ideal timing of delivery remains controversial, with some institutions advocating for earlier delivery to mitigate maternal risks while others prioritize fetal lung maturity(9). Furthermore, the choice between cesarean hysterectomy and uterus-preserving approaches such as segmental uterine resection or local resection with reconstruction continues to be debated, with each strategy carrying distinct risks and benefits that must be carefully weighed against patient characteristics such as desire for future fertility, and the depth of placental invasion. While hysterectomy minimizes the risk of catastrophic hemorrhage, it carries higher rates of bladder injury and loss of fertility. Uterus-preserving techniques, when feasible, may reduce morbidity and preserve reproductive potential, but require meticulous planning and intraoperative assessment(10).

Despite advances in our understanding of PAS, critical knowledge gaps persist. The long-term outcomes of different management strategies, particularly novel techniques such as segmental uterine resection and multidisciplinary team approaches, remain understudied. Additionally, there are limited data on how antenatal risk factors—including placental location, number of prior cesareans, and biochemical markers—may be leveraged to predict invasion severity and guide individualized treatment plans(11). This study seeks to address these gaps through a comprehensive analysis of maternal and neonatal outcomes in PAS cases managed at a high-volume tertiary center over a ten-year period. By examining the interplay between antenatal risk stratification, surgical management choices, and clinical outcomes, we aim to contribute evidence-based insights that can inform practice guidelines and improve care for this high-risk population.

Materials and Methods

This retrospective cohort study was conducted at the Department of Obstetrics and Gynecology, İnönü University Faculty of Medicine, after obtaining approval from the Institutional Non-Interventional Clinical Research Ethics Committee (approval date: 02.04.2024; approval number: 2024/5875). The study population comprised all pregnant women diagnosed with PAS and managed at our tertiary care center between January 1, 2014, and December 31, 2023. The diagnosis of PAS was confirmed either intraoperatively, based on direct visualization of abnormal placental adherence and invasion, or postoperatively through histopathological examination of specimens obtained after cesarean hysterectomy or uterus-preserving procedures.

Eligible participants were women aged between 18 and 48 years who delivered at our hospital and had a confirmed diagnosis of PAS. Exclusion criteria included multiple gestations and cases with incomplete clinical or follow-up data, such as insufficient antenatal visits or missing surgical records.

Data were obtained from the hospital’s electronic medical records and recorded into a standardized Excel database specifically designed for this study. Collected variables included maternal demographic and obstetric characteristics [age, gravidity, parity, body mass index (BMI), smoking status, history of previous cesarean deliveries, and history of other gynecological surgeries], comorbid conditions, and obstetric complications. Information regarding gestational age at diagnosis and delivery, diagnostic modality (ultrasound and/or MRI), antenatal corticosteroid administration, and indication for delivery was also documented.

Surgical data included the type of uterine incision, its relationship to placental location, the operative management strategy (cesarean hysterectomy versus uterus-preserving surgery), the anatomical location of the placenta, and the degree of placental invasion (placenta accreta, increta, or percreta). Intraoperative parameters, such as estimated blood loss, number of blood products transfused, and perioperative complications (including bladder and ureteral injuries), were recorded. Preoperative and postoperative laboratory results, specifically hemoglobin and hematocrit levels, were reviewed to evaluate perioperative hematologic changes. Neonatal outcomes included birth weight, 1- and 5-minute Apgar scores, need for neonatal intensive care unit (NICU) admission, and neonatal morbidity and mortality data.

Sample Size and Power Justification

Because this was a retrospective cohort including all eligible PAS cases managed over a 10-year period, no a priori sample size calculation was performed. The final cohort (n=210) provided >80% post hoc statistical power (α=0.05), based on observed effect sizes for perinatal mortality and intraoperative blood loss to detect clinically relevant differences in maternal and neonatal outcomes between elective and emergency delivery groups.

Statistical Analysis

Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 26.0 (IBM Corp., Armonk, NY, USA). Continuous variables were assessed for normality using the Kolmogorov-Smirnov test and expressed as mean ± standard deviation for normally distributed data or median (minimum-maximum) for non-normally distributed data. Categorical variables were presented as frequencies and percentages. For between-group comparisons, the Independent Samples t-test was applied to normally distributed continuous variables, while the Mann-Whitney U test was used for non-normally distributed variables. Associations between categorical variables were analyzed using Pearson’s chi-square test, Yates’ continuity correction, or Fisher’s exact test, as appropriate. To evaluate risk factors associated with adverse maternal and neonatal outcomes, univariate logistic regression analyses were performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Variables with a p-value <0.10 in univariate analysis were subsequently included in a multivariate logistic regression model to identify independent predictors. Multicollinearity was evaluated prior to model entry, and model fit was confirmed using the Hosmer-Lemeshow test.  A two-tailed p-value <0.05 was considered statistically significant for all analyses.

Results

Table 1 summarizes the demographic, obstetric, maternal, intraoperative, and neonatal characteristics of 210 women diagnosed with PAS. Continuous variables are presented as mean ± standard deviation and median (minimum-maximum), while categorical variables are expressed as counts and percentages.

Study Population Characteristics

A total of 210 women diagnosed with PAS were included in the study. Of these, 140 (66.7%) underwent planned surgery, while 70 (33.3%) required emergency intervention. Emergency procedures were primarily performed due to PAS-related hemorrhage in 44 cases (62.9%), while the remaining 26 patients (37.1%) required urgent surgery for other obstetric indications. In the planned group, 135 deliveries were performed due to PAS and 5 for other obstetric reasons. The demographic profile revealed a mean maternal age of 33.81±4.85 years, with patients demonstrating an average gravidity of 4.30±1.49 and parity of 2.83±1.22. The study population had a mean BMI of 30.60±4.05 kg/m2, consistent with the known association between obesity and PAS risk. Notably, the average number of prior cesarean deliveries was 2.09±0.98, underscoring the well-established link between uterine scarring and abnormal placentation.

Diagnostic and Clinical Parameters

The mean gestational age at PAS diagnosis was 26.37±5.62 weeks, with definitive management occurring at a mean of 34.71±3.54 weeks. Diagnostic modalities included grayscale ultrasound alone (20.47%), combined grayscale and color Doppler ultrasound (79.04%), and MRI confirmation (0.48%). Preoperative hemoglobin and hematocrit levels averaged 11.23±1.33 g/dL and 34.21±3.63%, respectively, with significant interindividual variability reflecting the spectrum of disease severity.

Comparative Analysis of Delivery Timing

The analysis revealed striking differences between planned and emergency deliveries. Emergency cases were delivered significantly earlier (mean gestational age: 32.13±4.57 weeks) compared to planned deliveries, (36.01±1.86 weeks, p <0.001), resulting in substantial neonatal consequences. This four-week disparity in gestational age had profound clinical implications, particularly for neonatal outcomes. Intraoperative blood loss was markedly higher in emergency cases (799.29±414.28 mL) versus planned deliveries (511.43±311.49 mL, p<0.001), though transfusion requirements did not differ significantly between groups (p>0.05). Emergency deliveries were associated with higher rates of intraoperative complications, increased NICU admission, higher need for respiratory support, and elevated perinatal mortality compared with elective procedures (Figure 1). Maternal intensive care unit (ICU) admission rates trended higher in emergency deliveries, though this difference did not reach statistical significance (Table 2).

Surgical Management Outcomes

The surgical approach varied significantly based on clinical presentation and intraoperative findings. A Sankey diagram (Figure 2) illustrates the distribution of PAS patients according to timing of surgery (emergency vs. elective), surgical procedure (hysterectomy vs. preventive surgery), and placental location (anterior vs. posterior). Among 210 women, 70 underwent emergency surgery and 140 elective surgery. Of these, 95 (45.2%) underwent hysterectomy and 115 (54.8%) underwent preventive surgery. Placental involvement was predominantly anterior (n=188, 89.5%), with only 22 cases (10.5%) demonstrating posterior invasion.

Anterior placental location was strongly associated with complete invasion and bladder involvement, whereas posterior placentas were mainly characterized by focal invasion and minimal organ involvement (Figure 3). The surgical approach varied significantly based on clinical presentation and intraoperative findings. Anterior placental location was observed in 188 patients (89.5%) and posterior location in 22 patients (10.5%). With respect to invasion type, 68 patients (32.4%) had placenta accreta, 58 (27.6%) had increta, and 84 (40.0%) had percreta. Complete invasion was more common (72.4%) than focal invasion (27.6%). Hysterectomy was performed in 95 cases (45.24%), while uterine-preserving techniques were attempted in 115 patients (54.76%). Among the conservative management group, 23 cases (20%) required conversion to hysterectomy intraoperatively due to uncontrolled hemorrhage, and 3 (2.6%) underwent delayed hysterectomy during the postoperative period. The hysterectomy group demonstrated higher rates of complete placental invasion (92.6% vs. 55.7%, p<0.001) and placenta percreta (60% vs. 23.5%, p<0.001). Surgical approach also differed significantly, with upper transverse incisions predominating in uterine-preserving cases (65.2%) versus classical incisions in hysterectomies (56.8%, p<0.001) (Table 3). In addition, the number of previous cesarean sections and the rate of perinatal death were higher in the hysterectomy group (Figure 4).

When comparing planned and emergency deliveries, there was no significant difference in preoperative or postoperative hemoglobin and hematocrit levels or in transfusion requirements. However, intraoperative blood loss was significantly higher in the emergency group (799.3±414.3 mL vs. 511.4±311.5 mL; p<0.001).

Neonatal Outcomes

The neonatal consequences of PAS were particularly pronounced in emergency deliveries. Infants born under emergent conditions had significantly lower birth weights (2147.91±858.94 g vs. 2863.32±455.17 g, p<0.001), reflecting their earlier gestational age at delivery. Apgar scores were markedly reduced in the emergency group at both 1-minute (6.33±1.63 vs. 7.35±1.22, p<0.001) and 5-minute assessments (8.01±1.94 vs. 9.11±1.36, p<0.001). NICU admission duration was nearly three times longer for neonates delivered emergently (6.74±8.14 days vs. 2.13±4.22 days, p<0.001). The emergency group also demonstrated higher rates of respiratory distress syndrome (RDS) (47% vs. 14%, p<0.001), intracranial hemorrhage (18.6% vs. 2.9%, p<0.001), and hypoxic-ischemic encephalopathy (10% vs. 2.1%, p =0.012). Most alarmingly, perinatal mortality was fourteen times higher in emergency deliveries (20% vs. 1.4%, p<0.001).

Placental Characteristics and Associated Morbidity

The study provided a detailed analysis of placental morphology and its clinical implications. Anterior placental location predominated (89.52%), with these cases demonstrating higher rates of complete invasion (77.7% vs. 27.3% in posterior placentas, p<0.001) and bladder involvement (27.7% vs. 4.5%, p=0.038). Posterior placentas were more likely to show focal invasion (72.7%) and were found in patients with significantly lower BMI (28.95±3.81 vs. 30.79±4.04, p=0.015) (Table 4). Surgical complications varied by placental location, with ureteral injury occurring exclusively in emergency cases (5.7% vs. 0%, p=0.024), while bladder injuries were more common in planned deliveries (22.9% vs. 18.6%, p=0.024).

Antenatal Management

Antenatal steroid administration showed significant variation between groups. Complete courses were more frequently administered in planned deliveries (39.3% vs. 24.3%, p<0.001), while incomplete dosing was more common in emergency cases (24.3% vs. 5%). This disparity in prenatal preparation likely contributed to the observed differences in neonatal outcomes.

Predictive Modeling

In the univariate logistic regression analysis evaluating factors associated with the mode of delivery, variables including maternal age, gravida, parity, BMI, smoking status, and number of previous cesarean sections were not significantly associated with delivery type (p>0.05) (Table 5).

Conversely, lower preoperative hematocrit was identified as a significant predictor of emergency delivery (OR: 1.092; 95% CI: 1.007-1.185; p=0.034), while preoperative hemoglobin level showed a borderline association (OR: 1.234; 95% CI: 0.992-1.534; p=0.059). In the multivariable model, preoperative hematocrit remained an independent predictor of emergency delivery after adjustment for BMI, number of prior cesarean sections, and placental location, supporting its potential clinical value as an early marker of adverse delivery timing.

Furthermore, in a separate multivariable analysis adjusting for maternal diabetes, hypertension, parity, and gestational age, emergency delivery continued to be independently associated with increased risk of neonatal RDS (adjusted OR: 2.7, 95% CI: 1.4-5.2) and perinatal death (adjusted OR: 3.8, 95% CI: 1.1-8.6), confirming the robustness of the observed associations.

Correlational Analysis

Table 6 summarizes the significant correlations observed in the emergency and elective cesarean section groups. In the emergency cesarean section group, maternal age was positively correlated with gravida (r=0.244; p=0.042), parity (r=0.321; p=0.007), and the number of previous cesarean deliveries (r=0.270; p=0.024). Increasing gestational age at delivery was negatively correlated with NICU stay duration (r=-0.385; p=0.001) and the presence of neonatal RDS (r=-0.582; p<0.001). Intraoperative blood loss was strongly correlated with erythrocyte transfusion requirement (r=0.880; p<0.001) and maternal ICU stay duration (r=0.692; p<0.001). In the elective cesarean section group, maternal age showed significant positive correlations with gravida (r=0.215; p=0.011), parity (r=0.206; p=0.014), BMI (r=0.261; p=0.002), and the number of previous cesarean deliveries (r=0.196; p=0.020). Intraoperative blood loss was positively correlated with erythrocyte transfusion (r=0.591; p<0.001) and maternal ICU stay duration (r=0.360; p<0.001).

On the other hand, in the hysterectomy group, maternal age showed a positive correlation with gravida (r=0.285, p=0.005), parity (r=0.232, p=0.024), and the number of previous cesarean sections (r=0.300, p=0.003). Parity was positively associated with gestational age at delivery (r=0.515, p<0.001), but negatively correlated with intraoperative blood loss (r=-0.240, p=0.019) and maternal ICU stay (r=-0.245, p=0.017). Gestational age was inversely correlated with neonatal ICU stay (r=-0.381, p<0.001) and neonatal RDS (r=-0.405, p<0.001). Intraoperative blood loss showed strong positive correlations with erythrocyte transfusion (r=0.575, p<0.001) and maternal ICU stay (r=0.369, p<0.001). Erythrocyte transfusion was positively associated with maternal ICU stay (r=0.606, p<0.001) and hospital stay (r=0.481, p<0.001). In the uterus-preserving surgery group, maternal age was positively correlated with gravida (r=0.202, p=0.030) and parity (r=0.198, p=0.034). Gestational age showed negative correlations with neonatal ICU stay (r=-0.482, p<0.001) and neonatal RDS (r=-0.609, p<0.001). Intraoperative blood loss was positively associated with erythrocyte transfusion (r=0.730, p<0.001), maternal ICU stay (r=0.563, p<0.001), hospital stay (r=0.436, p<0.001), and neonatal ICU stay (r=0.299, p=0.001). Erythrocyte transfusion was positively correlated with maternal ICU stay (r=0.718, p<0.001) and hospital stay (r=0.557, p<0.001) (Table 7).

Table 8 presents the correlation analysis of maternal and neonatal outcomes between the anterior and posterior placenta groups. In the anterior placenta group, maternal age was positively correlated with gravida (r=0.227, p=0.002), parity (r=0.264, p<0.001), BMI (r=0.253, p<0.001), and the number of previous cesarean sections (r=0.210, p=0.004). The number of previous cesarean sections correlated positively with erythrocyte transfusion (r=0.172, p=0.018). Gestational age at delivery was negatively correlated with intraoperative blood loss (r=-0.239, p=0.001), NICU stay (r=-0.437, p<0.001), and neonatal RDS (r=-0.557, p<0.001). Intraoperative blood loss correlated positively with erythrocyte transfusion (r=0.717, p<0.001), maternal ICU stay (r=0.529, p<0.001), hospital stay (r=0.348, p<0.001), NICU stay (r=0.225, p=0.002), and neonatal RDS (r=0.261, p<0.001). Erythrocyte transfusion was significantly associated with maternal ICU stay (r=0.652, p<0.001) and hospital stay duration (r=0.483, p<0.001). In the posterior placenta group, gravida was strongly correlated with parity (r=0.884, p<0.001), BMI (r=0.490, p=0.021), and the number of previous cesarean sections (r=0.699, p<0.001). Parity was also associated with BMI (r=0.427, p=0.047) and the number of previous cesarean sections (r=0.781, p<0.001). BMI showed a significant positive correlation with the number of previous cesarean sections (r=0.512, p=0.015). Gestational age at delivery was negatively correlated with NICU stay (r=-0.568, p=0.006). Erythrocyte transfusion was positively correlated with maternal ICU stay duration (r=0.768, p<0.001) and hospital stay duration (r=0.670, p=0.001).

Discussion

In this retrospective analysis of 210 patients diagnosed with PAS, we investigated the impact of antenatal risk factors, clinical presentation, and management strategies on maternal and neonatal outcomes. Our findings demonstrate that planned surgical intervention was associated with reduced intraoperative blood loss, higher gestational age at delivery, and improved neonatal outcomes compared to emergency interventions. These results reinforce the critical role of antenatal diagnosis and timely delivery planning in optimizing outcomes for both the mother and the neonate.

The observed predominance of anterior placental location in our cohort (89.5%) aligns with prior studies reporting anterior implantation as a significant risk factor for severe placental invasion, particularly in patients with multiple prior cesarean sections(12). Our data further indicate that anterior location was associated with higher rates of complete invasion and bladder involvement. These findings are consistent with earlier reports suggesting that anterior PAS may have a more aggressive clinical course and higher surgical complexity(13, 14). This underlines the importance of detailed prenatal imaging and multidisciplinary surgical preparation, especially in anteriorly located PAS cases.

Surgical management in our cohort favored hysterectomy in 58.6% of cases, with conservative uterus-preserving approaches used in 41.4% of cases, particularly in accreta and increta cases. This is comparable to previous large series, which reported hysterectomy rates ranging from 50% to 80% depending on disease severity and institutional protocols(15, 16). Moreover, accumulating evidence from recent high-quality studies strongly supports the clinical value of selective uterus-preserving surgical techniques in appropriately selected PAS patients(17-19). These techniques, including localized resection of the invaded myometrium, partial myometrial excision with uterine reconstruction, stepwise devascularization, and the placenta left in situ approach, have emerged as rational alternatives to routine peripartum hysterectomy, particularly in cases of focal or limited invasion and hemodynamic stability. Multiple observational series and meta-analyses have demonstrated that such uterus-preserving interventions are associated with significantly reduced operative time, lower intraoperative blood loss, and decreased transfusion requirements compared to hysterectomy, without compromising maternal survival(20).

In addition, uterus-preserving surgery confers important long-term advantages, including preservation of menstrual function and the potential for future pregnancy. From a healthcare systems perspective, these strategies have also been linked to reduced resource utilization—notably shorter ICU stays, fewer secondary surgical procedures, and lower overall hospital costs—when performed in tertiary referral centers with multidisciplinary PAS teams and standardized management protocols. Our present findings align closely with this growing body of evidence, reaffirming that the selective use of uterus-preserving techniques in appropriately selected patients, tailored to the extent of placental invasion, placental location, and maternal clinical condition, is pivotal for optimizing outcomes. Integrating precise antenatal imaging with multidisciplinary intraoperative coordination allows for balancing maternal safety with fertility preservation, thereby reflecting the contemporary paradigm shift from radical to selective management in PAS care.

A key statistical finding of our study was the strong and consistent negative correlation between intraoperative blood loss and postoperative hemoglobin/hematocrit levels across all subgroups, including anterior vs. posterior location, hysterectomy vs. uterus-preserving surgery, and emergency vs. planned deliveries. The magnitude of these correlations (Spearman r ranging from -0.45 to -0.68, all p<0.001) confirms the predictable hematologic impact of blood loss in PAS surgery. Moreover, multivariate logistic regression identified lower preoperative hematocrit as an independent predictor of emergency delivery (OR: 1.092; 95% CI: 1.007-1.185; p=0.034), suggesting that antenatal hematologic optimization may reduce the likelihood of urgent intervention. These findings are in agreement with previous reports that emphasize the importance of preoperative hemoglobin status in reducing intraoperative transfusion needs and improving hemodynamic stability(21, 22). These results also highlight the importance of meticulous surgical planning, early vascular control, and the availability of massive transfusion protocols.

Emergency delivery was required in one-third of patients, most commonly due to PAS-related hemorrhage. Current guidelines emphasize rapid intervention in cases with impending or active hemorrhage, which aligns with our findings, as emergency deliveries were associated with markedly higher intraoperative blood loss, lower neonatal birth weight, and increased NICU admissions compared with planned procedures(23). These results support previous studies reporting that unplanned surgery compromises maternal hemodynamic stability and worsens perinatal outcomes(24-26). Moreover, the strong association between reduced preoperative hematocrit and the need for emergency delivery observed in our multivariate analysis suggests that antenatal optimization of maternal hematologic status may represent a modifiable risk factor for reducing the likelihood of unplanned intervention.

Neonatal outcomes in our cohort reflected the gestational age at delivery, with lower Apgar scores and higher respiratory distress rates in the emergency delivery group. This underscores the dual benefit of planned intervention: not only is maternal morbidity reduced, but neonatal maturity and stability at birth are improved. Our findings are in line with international guidelines recommending delivery at a gestational age balancing fetal maturity and maternal safety, often between 34 and 36 weeks in PAS cases(27-29).

Regarding long-term outcomes, several recent investigations have shown that uterus-preserving management may enable successful subsequent pregnancies in carefully selected patients, provided that rigorous follow-up and structured surveillance protocols are implemented(30). However, subsequent pregnancies carry a measurable risk of recurrent abnormal placentation—most commonly placenta previa or recurrent PAS—highlighting the need for preconception counseling and delivery planning in tertiary centers with PAS expertise(31). From a maternal health perspective, conservative strategies have been associated not only with preservation of reproductive potential but also with improved psychological, and quality-of-life outcomes, particularly among women desiring future fertility(32). Long-term gynecologic sequelae, such as intrauterine adhesions or secondary infertility, appear uncommon when uterine repair is meticulous and postoperative infections are prevented through careful perioperative management. Moreover, structured and multidisciplinary care pathways that emphasize antenatal diagnosis, planned delivery, and optimized surgical coordination are consistently linked to lower blood transfusion requirements, shorter ICU stays, and reduced overall hospitalization time, translating into measurable cost savings for health systems. Economic analyses from recent multicenter studies indicate that planned conservative management, when applied in appropriate cases, can reduce total healthcare expenditure by up to 25-30% compared with emergency hysterectomy performed without prior antenatal diagnosis(33).

Study Limitations

A major strength of our study is the relatively large sample size of patients with histopathologically confirmed PAS, allowing for meaningful subgroup analyses by placental location, surgical approach, and timing of delivery. The inclusion of detailed maternal, surgical, and neonatal outcomes, combined with correlation and regression analyses, provides a comprehensive assessment of the clinical course of PAS in a real-world tertiary care setting. Additionally, our focus on the predictive value of preoperative hematocrit for emergency delivery offers a potentially actionable clinical parameter for antenatal risk stratification.

However, several limitations should be acknowledged. The retrospective design inherently carries the risk of selection and information bias, particularly in the completeness of medical records. The study was conducted in a single tertiary referral center, which may limit the generalizability of the results to lower-resource or non-specialized settings. Furthermore, although surgical decision-making was standardized to an extent, variations in surgeon experience and intraoperative judgment could have influenced outcomes. In our center, although all procedures were performed by obstetric surgeons with expertise in high-risk obstetrics and PAS management, subtle differences in surgical judgment—such as the decision to proceed with uterus-preserving management versus radical management, the threshold for hysterectomy, or the intraoperative use of hemostatic and reconstructive techniques—may have impacted both maternal and neonatal outcomes. This inherent heterogeneity in operator experience is a well-recognized limitation in PAS research and contributes to interstudy variability reported in the literature. Differences in team composition, intraoperative resource availability, and surgeon familiarity with advanced uterus-preserving procedures may also act as confounding factors, particularly in retrospective analyses where allocation to a specific surgical approach cannot be fully randomized or blinded. Furthermore, emergent situations often necessitate rapid decision-making under suboptimal conditions, amplifying the effect of individual expertise on surgical outcomes. Although the use of institutional management protocols and multidisciplinary coordination minimizes this variability to some extent, the absence of a fully standardized decision-making algorithm across all surgeons remains an important source of potential bias. Finally, neonatal outcomes were influenced by multiple factors beyond the scope of PAS, including comorbidities and antenatal events, which could not be fully controlled in the analysis.

Conclusion

This study demonstrates that early diagnosis and planned delivery in cases of PAS are critical for optimizing both maternal and neonatal outcomes. Emergency deliveries were associated with lower gestational age at birth, increased intraoperative blood loss, and higher rates of adverse neonatal outcomes, including low birth weight, reduced Apgar scores, prolonged NICU stay, and increased risk of RDS and other serious complications. Surgical management strategies varied according to the type and extent of placental invasion, with uterus-preserving approaches more frequently adopted in focal PAS and hysterectomy preferred in complete invasion or percreta cases. The choice of uterine incision was also influenced by placental location and invasion type, underscoring the importance of individualized surgical planning.

These findings highlight the necessity of multidisciplinary collaboration and careful preoperative planning to reduce maternal morbidity and improve neonatal prognosis. Incorporating detailed antenatal imaging, risk stratification, and timely delivery planning into routine care pathways can significantly mitigate the risks associated with PAS. Future prospective, multicenter studies are warranted to validate these findings and refine management guidelines.

Ethics

Ethics Committee Approval: This retrospective cohort study was conducted at the Department of Obstetrics and Gynecology, İnönü University Faculty of Medicine, after obtaining approval from the Institutional Non-Interventional Clinical Research Ethics Committee (approval date: 02.04.2024; approval number: 2024/5875).
Informed Consent: Retrospective study.

Authorship Contributions

Concept: L.O., R.M., Design: L.O., R.M., E.Y., Data Collection or Processing: L.O., R.M., H.Ö., Analysis or Interpretation: Ş.Y., Literature Search: R.M., Writing: R.M., E.Y., H.Ö., Ş.Y.
Conflict of Interest: Ercan Yılmaz MD is editor-in-chief in Turkish Journal of Obstetrics and Gynecology. He had no involvement in the peer-review of this article and had no access to information regarding its peer-review.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Jauniaux E, Jurkovic D, Hussein AM, Burton GJ. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022;227:384-91.
2
Escobar MF, Gallego JC, Nasner D, Gunawardana K. Management of abnormal invasive placenta in a low- and medium-resource setting. Best Pract Res Clin Obstet Gynaecol. 2021;72:117-28.
3
Nieto-Calvache AJ, Palacios-Jaraquemada JM, Hussein AM, Jauniaux E, Milani Coutinho C, Rijken M. Management of placenta accreta spectrum in low- and middle-income countries. Best Pract Res Clin Obstet Gynaecol. 2024;94:102475.
4
Rauf M, Ebru C, Sevil E, Selim B. Conservative management of post-partum hemorrhage secondary to placenta previa-accreta with hypogastric artery ligation and endo-uterine hemostatic suture. J Obstet Gynaecol Res. 2017;43:265-71.
5
Waller J, Shamshirsaz A, Abuhamad A. Advances in imaging for placenta accreta spectrum disorder. Obstet Gynecol. 2025;145:621-7.
6
Patel-Lippmann KK, Planz VB, Phillips CH, Ohlendorf JM, Zuckerwise LC, Moshiri M. Placenta accreta spectrum disorders: update and pictorial review of the SAR-ESUR joint consensus statement for MRI. Radiographics. 2023;43:e220090.
7
Waller J, Abuhamad A. Imaging modalities for the diagnosis of placenta accreta spectrum. Clin Obstet Gynecol. 2025;68:242-50.
8
Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al.; International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220:511-26.
9
Rosenthal EA, White A, Lafferty AK, Pruszynski JE, Spong CY, Herrera CL. Delivery timing of placenta accreta spectrum: later is feasible. Am J Obstet Gynecol. 2025:S0002-9378(25)00108-5.
10
Matsuzaki S, Einerson BD, Sentilhes L, Sibai BM, Saade GR, Saad AF, et al. Local resection after cesarean delivery for placenta accreta spectrum disorder: a systematic review and meta-analysis. Obstet Gynecol. 2025;145:639-53.
11
Shazly SA, Hortu I, Shih JC, Melekoglu R, Fan S, Ahmed FUA, et al.; and Middle East Obstetrics and Gynecology Graduate Education (MOGGE) foundation – Artificial intelligence (AI) unit. Prediction of clinical outcomes in women with placenta accreta spectrum using machine learning models: an international multicenter study. J Matern Fetal Neonatal Med. 2022;356644-53.
12
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146:20-4.
13
Liu H, Zhang B, Wang W, Li H, Huang X, Wang J, et al. Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum. BMC Pregnancy Childbirth. 2023;23:406.
14
White A, Malik M, Pruszynski JE, Do QN, Spong CY, Herrera CL. Contemporary placenta accreta spectrum disorder incidence and risk factors. Obstet Gynecol. 2025;145:665-73.
15
Pan S, Han M, Zhai T, Han Y, Lu Y, Huang S, et al. Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024;24:463.
16
Sentilhes L, Seco A, Azria E, Beucher G, Bonnet MP, Branger B, et al.; PACCRETA Study Group. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2022;226:839.e1-839.e24.
17
Pinto PV, Freitas G, Vieira RJ, Aryananda RA, Nieto-Calvache AJ, Palacios-Jaraquemada JM. Placenta accreta spectrum disorder: a systematic review and meta-analysis on conservative surgery. Int J Gynaecol Obstet. 2025 Jun 24.
18
Barinov SV, Di Renzo GC. A new technique to preserve the uterus in patients with placenta accreta spectrum disorders. Am J Obstet Gynecol. 2024;230:S1107-15.
19
Paping A, Bluth A, Al Naimi A, Mhallem M, Kolak M, Jaworowski A, et al.; IS-PAS. Opportunities for, and barriers to, uterus-preserving surgical techniques for placenta accreta spectrum. Acta Obstet Gynecol Scand. 2025;104(Suppl 1):8-19.
20
Hessami K, Kamepalli S, Lombaard HA, Shamshirsaz AA, Belfort MA, Munoz JL. Conservative management of placenta accreta spectrum is associated with improved surgical outcomes compared to cesarean hysterectomy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025;232:432-452.e3.
21
Kloka JA, Friedrichson B, Jasny T, Blum LV, Choorapoikayil S, Old O, et al. Anaemia and red blood cell transfusion in women with placenta accreta spectrum: an analysis of 38,060 cases. Sci Rep. 2024;14:4999.
22
Zhang B, Liu H, Li H, Wang J, Zhu H, Yu P, et al. Obstetric blood transfusion in placenta previa patients with prenatal anemia: a retrospective study. BMC Pregnancy Childbirth. 2024;24:92.
23
Bonanni G, Lopez-Giron MC, Allen L, Fox K, Silver RM, Hobson SR, et al. Guidelines on placenta accreta spectrum disorders: a systematic review. JAMA Netw Open. 2025;8:e2521909.
24
Zhan Y, Lu E, Xu T, Huang G, Deng C, Chen T, et al. Cesarean hysterectomy in pregnancies complicated with placenta previa accreta: a retrospective hospital-based study. BMC Pregnancy Childbirth. 2024;24:634.
25
Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212:561-8.
26
Morlando M, Schwickert A, Stefanovic V, Gziri MM, Pateisky P, Chalubinski KM, et al.; International Society for Placenta Accreta Spectrum (IS-PAS). Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: a multinational database study. Acta Obstet Gynecol Scand. 2021;100(Suppl 1):41-9.
27
Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management. Int J Gynaecol Obstet. 2018;140:281-90.
28
Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine; Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219:B2-16.
29
Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al.; Royal College of Obstetricians and Gynaecologists. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG. 2019;126:e1-e48.
30
Ohayon A, Castel E, Friedrich L, Mor N, Levin G, Meyer R, et al. Pregnancy outcomes after uterine preservation surgery for placenta accreta spectrum: a retrospective cohort study. Am J Perinatol. 2025;42:68-74.
31
Baldwin HJ, Nippita TA, Torvaldsen S, Ibiebele I, Ford JB, Patterson JA. Outcomes of subsequent births after placenta accreta spectrum. Obstet Gynecol. 2020;136:745-55.
32
Kuppermann M, Learman LA, Schembri M, Gregorich SE, Jackson RA, Jacoby A, et al. Contributions of hysterectomy and uterus-preserving surgery to health-related quality of life. Obstet Gynecol. 2013;122:15-25.
33
Morgan JC, Hripko EN, Einerson BD, Premkumar A. Intended conservative management versus caesarean hysterectomy for known or suspected placenta accreta spectrum: a cost-effectiveness analysis. BJOG. 2025;132:1096-103.